NAFLD & Diabetes

This feed focuses on Non-Alcoholic Fatty Liver Disease (NAFLD) in diabetic patients, which can lead to increased medical complications, such as cirrhosis.

September 22, 2020
Open Access

Circulating miR-216a as a biomarker of metabolic alterations and obesity in women

Non-coding RNA Research
Indira G C VonhögenChahinda Ghossein-Doha
September 16, 2020

Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study

Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition
Mohsen MazidiMaciej Banach
September 17, 2020
Open Access

Non-alcoholic fatty liver disease

Clinical Medicine : Journal of the Royal College of Physicians of London
Wenhao Li, William Alazawi
September 20, 2020

Multi-dimensional clinical phenotyping of a national cohort of adult cystic fibrosis patients

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Douglas J ConradRaksha Jain
September 23, 2020

Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19

Thrombosis and Haemostasis
Grigoris T GerotziafasIsmail Elalamy
September 15, 2020

Cognitive Impairment and Associated Factors in Rural Elderly in North China

Journal of Alzheimer's Disease : JAD
Jing WangXiaomei Li
September 16, 2020
Review

The Impact of Non-alcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective

The American Journal of Medicine
Amr DokmakHirsh D Trivedi
September 15, 2020
Open Access

Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis

Hepatology Communications
Sang Bong AhnPatricia C Valery
September 19, 2020
Review

A look to the future in non-alcoholic fatty liver disease: Are GLP-1 analogues or SGLT-2 inhibitors the answer?

Diabetes, Obesity & Metabolism
Rebecca K VincentMarc Evans
September 21, 2020
Review

Silymarin is an ally against insulin resistance: a review

Annals of Hepatology
Karla MacDonald-RamosMarco Cerbón
September 20, 2020

Anti-Diabetic Obesity Effects of Wasabia Japonica Matsum Leaf Extract on 45% Kcal High-Fat Diet-Fed Mice

Nutrients
Beom-Rak ChoiSae-Kwang Ku
September 22, 2020

Peri-Complication Diagnosis of Hepatitis C Infection: Risk Factors and Trends over Time

Liver International : Official Journal of the International Association for the Study of the Liver
Lauren Lapointe-ShawJordan J Feld
September 23, 2020

Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population

Journal of Clinical Medicine
Sara SokootiStephan J L Bakker

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2020 Meta ULC. All rights reserved
/feed-previews/nafld-diabetes/f8fe47c0-8113-49b6-a878-c1622a9bb497